Enanta Pharmaceuticals Inc (ENTA)
Net Income Growth
31.28%
TTM · Period ending:
ENTA Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported31.28%period ending
Latest reported31.28%period ending
ENTA TTM Net Income YoY % (-53.32% → 31.28%)
Year-over-year change
High-resolution chart · PNG
ENTA net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 31.2807% | |
| 35.7112% | |
| 31.8228% | |
| 29.4334% | |
| 20.2178% | |
| 26.812% | |
| 24.0956% | |
| 13.2802% | |
| 12.6673% | |
| -5.6491% | |
| -14.5997% | |
| -9.906% | |
| -10.042% | |
| -11.0051% | |
| -19.6888% | |
| -54.1281% | |
| -43.3113% | |
| -51.8404% | |
| -73.9467% | |
| -118.4141% | |
| -3,642.2166% | |
| -412.6093% | |
| -271.3411% | |
| -177.9768% | |
| -96.3412% | |
| -69.6073% | |
| -60.8051% | |
| -35.5398% | |
| -20.2754% | |
| 48.7942% | |
| 150.9205% | |
| 306.3015% | |
| 493.4175% | |
| 494.9434% | |
| 461.8121% | |
| -18.259% | |
| -170.3552% | |
| -140.4284% | |
| -115.0431% | |
| -72.5719% | |
| -57.0284% | |
| -71.6912% | |
| -22.7887% | |
| 129.3745% | |
| 94.4744% | |
| 704.4325% | |
| 562.2429% | |
| 257.7231% | |
| 249.7405% | |
| -279.7654% | |
| -138.0522% | |
| -55.0119% | |
| -53.3222% |